Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Oral Solution for Pediatric Sedation Before Medical Procedures
CTR20201526Phase 3Completed
- Sponsor
- Xinjiang Tefeng Pharmaceutical
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midazolam in anxiety disorder, preoperative anxiety, sponsored by Xinjiang Tefeng Pharmaceutical. Started Aug 2020; status: completed.
02
Drugs
midazolam
03
Conditions
anxiety disorderpreoperative anxiety
Beyond the preview
Go deeper on CTR20201526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201526.